cerrar
Tagged with P

Cannabinoid Drugs, Medicinal Cannabis and Opioid Drugs: Russia
All legal aspects surrounding cannabinoid drugs, medicinal cannabis and opioid drugs in Russia. Prepared in association with Lidings, a leading global…

Regulatory Reform: Russia
Upcoming reforms in Russia's pharma environment. Prepared in association with Lidings, a leading global law firm, this is an extract from The Pharma…

Patents and Trademarks: Russia
All about patents and trademarks in Russia. Prepared in association with Lidings, a leading global law firm, this is an extract from The Pharma…

Product Liability: Russia
The lowdown on the situation regarding the product liability in Russian Pharma. Prepared in association with Lidings, a leading global law firm, this…

Traditional Medicines and OTC Products: Russia
A brief overview of the situation regarding traditional medicines and OTC products in Russia. Prepared in association with Lidings, a leading global…

Marketing, Manufacturing, Packaging & Labeling, Advertising:…
Learn more about marketing, manufacturing, packaging & labeling, and advertising in Russian pharma. Prepared in association with Lidings, a…

Preclinical and Clinical Trial Requirements: Russia
All about preclinical and clinical trial requirements in Russia. Prepared in association with Lidings, a leading global law firm, this is an extract…

Regulatory, Pricing and Reimbursement Overview: Russia
An intro to the legal situation for regulatory, pricing and reimbursement in Russia. Prepared in association with Lidings, a leading global law firm,…

Beh Kian Teik – Deputy CEO, National Research Foundation…
Beh Kian Teik of Singapore’s National Research Foundation (NRF) outlines the importance of the life sciences within the country’s innovation…

Abhay Bangi – Partner, Life Sciences & Healthcare Lead…
EY’s Abhay Bangi highlights the key trends across the ASEAN life sciences space, how the COVID-19 pandemic has accelerated them, and charts…

Aileen Lai – CEO & Founder, HealthBeats
Innovation is at the heart of healthcare transformation and the doors for a much-needed shift from provider- to patient-centric solutions have been…

China Enters CAR-T Era with Fosun-Kite Yescarta Approval
A historic approval for Fosun-Kite’s CAR-T therapy Yescarta in China looks set to pave the way for further developments in the Chinese cell and gene…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here